pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Orthopedics · news · pharmadog
← back to Orthopedics
News · Orthopedics
109
stories
4d
Novartis pens $7.8B deal for Abogen's in vivo autoimmune T-cell engager
fiercebiotech
6d
PhRMA names next CEO; Pierre Fabre takes third swing at Ebvallo approval
biopharma dive
6d
Superior weight loss, blood sugar control propel Lilly’s amylin-GIP/GLP-1 combo into Phase 3
biospace
8d
FDA nod for Mirum’s Atebrioz makes 3 options for ultra-rare bone disease
biospace
8d
Regenerative medicine needs more than stem cells
biospace
8d
Milestone Sanfilippo nod helps Ultragenyx regroup after tough Angelman defeat
biospace
11d
FDA approves Mirum’s drug for ultra-rare soft tissue disease
endpoints
11d
J&J, Legend tout long-term survival benefits for Carvykti in multiple myeloma
biospace
13d
STAT+: Drugmakers, biotech VCs show ‘reinvigorated’ interest in osteoporosis treatments
stat
15d
Are healthcare systems really ready for GLP-1s?
biopharma dive
18d
In Sudan, attacks on hospitals force patients to make dangerous journeys
stat
18d
Opinion: More young men are coming to me for plastic surgery. The way I think about them has changed
stat
18d
Opinion: Doctors should educate patients about ‘Asian glow’ and drinking risks
stat
20d
5 biotechs braving the commercial waters with product launches
biospace
21d
STAT+: Medicare to expand its pilot that pays for technology to manage chronic diseases
stat
21d
Blood centers can help biopharma scale cell and gene therapies
biospace
22d
Scholar Rock SMA drug approved by FDA
biopharma dive
22d
Pennsylvania records third measles-related death amid outbreak
stat
23d
J&J looking to offload orthopedics unit in $20B deal to Apollo: Bloomberg
fiercebiotech
28d
Structure’s obesity portfolio impresses on GLP-1 and amylin fronts in dual data drop
biospace
28d
Hospitals pursue deals to ensure survival as Trump’s Medicaid cuts loom
stat
Sep 3, 26
Chutes & Ladders—Invivyd's chairman adds CEO role ahead of COVID readout
fiercebiotech
Sep 3, 26
Ultragenyx’s 'high-risk' Angelman bet fails, cratering stock and forcing strategic review
biospace
Sep 3, 26
AbbVie’s bispecific T-cell engager shows promise in ph. 3 multiple myeloma trial
fiercebiotech
Sep 3, 26
Ultragenyx fails phase 3 Angelman test, plots ‘significant expense reductions’
fiercebiotech
Sep 2, 26
TScan axes 75% of workforce to make room for solid tumor programs
fiercebiotech
Sep 1, 26
Is Moderna, Merck's mRNA cancer vaccine win the start of a 'personalized medicine revolution'?
fiercebiotech
Sep 1, 26
Roche inks $1.53B deal for Simcere’s B-cell-targeting antibody
fiercebiotech
Aug 31, 26
A winner, a loser, and a mid-stage signal from a major cardiology research conference
stat
Aug 31, 26
STAT+: Cadre of radiopharmaceuticals experts pushes the bounds in cancer therapy
stat
← prev
page 1 of 4
next →
